P32 NOVEL ASPECTS IN HORMONAL TREATMENT, BIOMARKERS AND PROGNOSTIC FACTORSThursday, 27 March, 14.00-15.30, Red Hall 2QUALITY OF LIFE EFFECTS OF INTERMITTENT AND CONTINUOUS HORMONAL THERAPY BY CYPROTERONE ACETATE (CPA) FOR METASTATIC PROSTATE CANCER
Thursday, 27 March, 14.00-15.30, Red Hall 2
References (0)
Cited by (0)
Copyright © 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved.